Spectral Medical's Stock Target Lowers to $0.35

Market by 2FIRSTS.ai
Spectral Medical's Stock Target Lowers to $0.35
Spectral Medical's stock target lowered to $0.35 by Stifel Nicolaus, impacting the company's position in the tobacco industry.

According to BayStreet's report on October 24th, the stock price target of Spectral Medical, a manufacturer of smokeless products, has been downgraded from 0.40 CAD to 0.35 CAD by stock analyst Stifel Nicolaus in a research report.


According to reports, Standard Diversified Inc is a holding company that owns and operates subsidiary companies in various industries, including other tobacco products, insurance, and outdoor advertising. They engage in the production and marketing of both smokeless and smoking tobacco products, as well as next-generation tobacco products. Their divisions manufacture and market moist snuff, and also serve as contract manufacturers and marketers of chewing tobacco products.


This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.